VAERS reports by lot

Sanofi Pasteur DTaP/Tdap lot U6321AA: VAERS reports

22 VAERS reports list lot U6321AA as a Sanofi Pasteur DTaP/Tdap vaccine, received between 2019-08-09 and 2021-09-04. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
22
Reports
5%
Marked serious
0
With a death outcome
12
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction1939%
Gastrointestinal816%
Allergic / Anaphylactic612%
General / Systemic (non-local)612%
Neurological510%
Musculoskeletal36%
Respiratory12%
Dermatological (non-injection-site)12%

Where reports came from

U.S. state of the reporter, where given (top 12).

California4
Washington3
Pennsylvania3
Ohio3
Georgia2
Delaware1
New York1
District of Columbia1
Indiana1
Virginia1
Maryland1
Nebraska1

Reports by month received

2019-083
2019-096
2019-101
2019-111
2019-121
2020-012
2020-061
2020-071
2020-082
2020-111
2021-061
2021-092

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.